Gutman cautioned that investors should not assume pet GLP-1s will mirror the explosive commercial success of human obesity drugs
Management expects CagriSema to generate 25% weight loss after 68 weeks of treatment
But maintaining weight loss after transitioning off GLP-1s requires improving the systems that regulate hunger, energy, muscle mass, blood sugar, recovery, hormones, inflammation, and metabolic flexibility
Insurance Coverage Note: According to Yucca Health's FAQ, the platform does not accept insurance
How should brands design fragrance experiences in light of these changes
Report any side effects, such as nausea or changes in appetite, to your healthcare provider promptly